Fox- 04 DRI

FOXO4-DRI

FOXO4-DRI is an experimental peptide investigated in preclinical research involving cellular senescence and mechanisms associated with aging.

FOXO4 and p53 are proteins involved in cellular stress responses, survival, and apoptosis. FOXO4-DRI has been studied for its potential to interfere with the FOXO4-p53 interaction, a pathway researchers have investigated in relation to the survival of senescent cells.

Preclinical studies have explored whether disruption of this interaction may influence apoptosis in certain senescent cell populations and affect markers associated with tissue homeostasis and age-related biological processes.

Research Areas

FOXO4-DRI has been investigated in areas including:

● Cellular senescence

● FOXO4-p53 signaling

● Apoptosis pathways

● Senescent-cell biology

● Cellular stress responses

● Tissue homeostasis

● Age-related biological mechanisms

Research Status

Research involving FOXO4-DRI remains preclinical and experimental. Findings reported in laboratory and animal models should not be interpreted as demonstrating safety, efficacy, or clinical benefit in humans.

FOXO4-DRI is not FDA-approved for human therapeutic use.

For Research Use Only. Not for human or veterinary use or consumption. Reign does not provide medical advice, dosing guidance, administration instructions, or recommendations for human use. This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.